Sales growth of 19.0% · Like-for-like sales increase of +10.0% · Adjusted EBITDA up at £11.8m (+30.4%) · Adjusted EPS 12.9p (+34.5%) · Net debt £28.7m (June 2014: £31.3m) · Ten practice surgeries acquired during the period · Five surgeries acquired after the period end · Loyalty scheme membership increased by almost 39% since December 2013 to 192,000
20 Mar '15
Better than expected results,growing company,secure market,focus on shareholders,planned growth.Does it for my portfolio. BUY BUY BUY
13 Feb '15
Nothing to do with Kleeneze
The post below has nothing at all to do with CVSG that company is CVSL.
6 Feb '15
taken on kleeneze.
new acquisition from findel plc. http://www.investegate.co.uk/findel-plc--fdl-/rns/disposal/201502060930022176E/
8 Dec '14
Target was 450
I set this target a couple of weeks back and it's hit it, looking at the brokers I guess 480 looks feasible, any ideas?
29 Nov '14
Interested in whether this will pass the mental barrier of 400 ready for the next leg up which seems to occur, if not then there shouldn't be much of a slide!
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.